Reply to: Signal Worth Trusting-If We Can Reproduce It: Clarifying Overall Response Rate and Progression-Free

Juliet Gray1, Rebekah Weston1, Simon Gates1

  • 1Juliet Gray, PhD, FRCPCH, Centre for Cancer Immunology, University of Southampton, Southampton, United Kingdom, Rebekah Weston, PhD, FRCPCH and Simon Gates, PhD, DIC, FHEA, Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom, Lucas Moreno, MD, PhD, Hospital Vall d'Hebron, Barcelona, Spain.

Abstract

No abstract available in PubMed .

Related Concept Videos